Clinical Trial

INSPIRE Pipeline™ Shield Post Approval Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the Pipeline™ Flex Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Shield PAS") is to collect on-label use data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Flex Embolization Device with Shield Technology™ ("Pipeline™ Shield Device") in a real-world post approval setting within the United States.
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-07 -> 2027-01 2026-08-11
Trial Details
NCT Number NCT05071963
Lead Sponsor Medtronic Neurovascular Clinical Affairs
Conditions Intracranial Aneurysm
Enrollment 246 participants
Start Date 2021-12-20
Primary Completion 2027-01 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-08-10